Viatris (VTRS) Change in Inventory (2020 - 2026)
Viatris (VTRS) posted quarterly Change in Inventory of $123.0 million for Q1 2026, down 36.5% year-over-year from $193.7 million in Q1 2025, and up 878.48% quarter-over-quarter from -$15.8 million in Q4 2025.
Viatris (VTRS) Change in Inventory (2020 - 2026) Analysis & Trends
Viatris' Change in Inventory history runs 7 years deep, the most recent figure standing at $123.0 million for Q1 2026.
- In Q1 2026, Change in Inventory fell 36.5% year-over-year to $123.0 million; the TTM figure through Mar 2026 stood at $35.7 million (down 93.47% YoY), while the FY2025 annual figure was $106.4 million, down 85.29% from the prior year.
- Change in Inventory for Q1 2026 stood at $123.0 million, up from -$15.8 million in the prior quarter.
- The five-year high for Change in Inventory was $370.4 million in Q1 2024, with the low at -$180.1 million in Q4 2022.
- The 5-year median for Change in Inventory is $127.6 million (2023), against an average of $107.4 million.
- Peak annual rise in Change in Inventory reached 1578.22% in 2022, while the deepest fall reached 335.42% in 2022.
- Viatris' Change in Inventory stood at -$180.1 million in 2022, then soared by 170.85% to $127.6 million in 2023, then tumbled by 72.1% to $35.6 million in 2024, then plunged by 144.38% to -$15.8 million in 2025, then soared by 878.48% to $123.0 million in 2026.
- Business Quant data shows VTRS's Change in Inventory at $123.0 million in Q1 2026, -$15.8 million in Q4 2025, and -$110.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -59.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 23.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -209.58 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 17.70 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 99.50 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 6.50 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alkermes | 8.07 Bn | 7.41 Bn | 397.90 Mn | -7.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 99.50 Mn |
| Jun 30, 2026 | 99.50 Mn |
| Mar 31, 2026 | 123.00 Mn |
| Mar 31, 2026 | 123.00 Mn |
| Dec 31, 2025 | -15.80 Mn |
| Dec 31, 2025 | -15.80 Mn |
| Sep 30, 2025 | -110.50 Mn |
| Sep 30, 2025 | -110.50 Mn |
| Jun 30, 2025 | 39.00 Mn |
| Jun 30, 2025 | 39.00 Mn |
| Mar 31, 2025 | 193.70 Mn |
| Mar 31, 2025 | 193.70 Mn |
| Dec 31, 2024 | 35.60 Mn |
| Dec 31, 2024 | 35.60 Mn |
| Sep 30, 2024 | 129.00 Mn |
| Sep 30, 2024 | 129.00 Mn |
| Jun 30, 2024 | 188.40 Mn |
| Jun 30, 2024 | 188.40 Mn |
| Mar 31, 2024 | 370.40 Mn |
| Mar 31, 2024 | 370.40 Mn |